Remote access technologies expose home care firms to cybersecurity vulnerabilities, experts say
By
Adam Healy
Apr 23, 2024
To make sure data do not fall into the wrong hands, providers need to stay current on the latest cybersecurity practices.
Workforce, advocacy, provider support comprise new LeadingAge strategic plan
By
Kimberly Bonvissuto
Apr 18, 2024
WASHINGTON, DC—On the second day of LeadingAge’s Leadership Summit 2024 here, Board Chair Roberto Muñiz, president and CEO of New Jersey-based Parker Health Group, urged members to share their stories...
‘Nanopaint’ breakthrough could give seniors a picture-perfect recovery from heart surgery, dialysis
By
Aaron Dorman
Mar 12, 2024
In the future, surgeons could use “nanopaint” particles to coat veins to prevent clogging after vein transplant procedures, research shows.
Actions & Transactions, July 22
By
Kathleen Steele Gaivin
Jul 22, 2024
Coldwell Banker brokers $33.7M sale of active adult community in Huntington Park, CA … MorningStar Senior Living celebrates grand opening of Old Town community in Fort Collins, CO … TMG arranges sale...
Spending on nursing homes, home care slows year over year
By
Kathleen Steele Gaivin
Jun 27, 2024
Between May 2023 and May 2024, overall healthcare costs grew by 3.4%, the fastest increase seen since December 2007, according to Altarum’s monthly Health Sector Economic Indicators brief, released Wednesday.
Gabapentinoids linked to increased risk for severe exacerbation in COPD
Jan 16, 2024
Compared with matched nonusers, gabapentinoid users have an increased risk across indications of epilepsy, neuropathic pain and other chronic pain.
Online training program for assisted living develops out of home care program
By
Kimberly Bonvissuto
Nov 03, 2023
An online training program for assisted living caregivers is being developed and tested based on another program that was created for unlicensed caregivers of people living in the greater community.
FDA approves Wezlana for multiple inflammatory diseases
Nov 02, 2023
Approval of the biosimilar allows for interchangeable use with Stelara in both adult and pediatric patients
FDA approves Capvaxive pneumococcal 21-valent conjugate vaccine
Jun 21, 2024
Merck says the vaccine covers serotypes responsible for approximately 84% of invasive pneumococcal disease in adults aged 50 or more years.
Senior living affordability, workforce development at center of revamped SENIOR Act
By
Kimberly Bonvissuto
Mar 11, 2024
Workforce development and increased access to assisted living are the key provisions of an updated bipartisan bill backed by Argentum.